BioconBCLTF
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$4.21avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Biocon Ltd. (BCLTF) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Stanley-Laman Group, Ltd. ($3.4M) and Boston Common Asset Management, LLC ($2.3M).
- Company
- Biocon Ltd.
- CUSIP
- Y0905C102
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 4,059 shares sold, net −4,059 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Stanley-Laman Group, Ltd. | 0.45% | No change | 800,000 | $3.4M |
| Boston Common Asset Management, LLC | 0.06% | Reduce -0.7% | 549,512 | $2.3M |
"% of holder's portfolio" is BCLTF's weight in each manager's 13F, not the share of Biocon Ltd. the manager owns.